UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015918
Receipt number R000018528
Scientific Title Association between serum bilirubin concentrations and diabetic nephropathy
Date of disclosure of the study information 2014/12/11
Last modified on 2021/01/02 05:59:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association between serum bilirubin concentrations and diabetic nephropathy

Acronym

Association between serum bilirubin concentrations and diabetic nephropathy

Scientific Title

Association between serum bilirubin concentrations and diabetic nephropathy

Scientific Title:Acronym

Association between serum bilirubin concentrations and diabetic nephropathy

Region

Japan


Condition

Condition

diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Recently, bilirubin has been paid attention as a strong endogenous antioxidant. The present study will be undertaken to reveal the association between bilirubin concentrations and diabetic nephropathy.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

eGFR

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with diabetes (N=439) who visited Kyushu University Hospital in April to June 2006 were recruited.

Key exclusion criteria

participants were enrolled after excluding hemolytic disease or alerted hepatic function or Gilbert syndrome or hyperfiltration.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Toyoshi
Middle name
Last name Inoguchi

Organization

Kyushu university

Division name

Innovation Center for Medical Redox Navigation

Zip code

8128582

Address

3-1-1 maidashi higashi-ku Fukuoka 812-8582, Japan

TEL

0926425284

Email

toyoshi@intmed3.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Toyoshi
Middle name
Last name Inoguchi

Organization

Kyushu university

Division name

Innovation Center for Medical Redox Navigation

Zip code

8128582

Address

3-1-1 maidashi higashi-ku Fukuoka 812-8582, Japan

TEL

0926425284

Homepage URL


Email

toyoshi@intmed3.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu university

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research from the Ministry of Education, Scientific and Culture, Japan

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyushu university hospital

Address

3-1-1 maidashi higashi-ku Fukuoka 812-8582, Japan

Tel

+81 92 642 5774

Email

ijkseimei@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 11 Day


Related information

URL releasing protocol

unpublished

Publication of results

Unpublished


Result

URL related to results and publications

unpublished

Number of participants that the trial has enrolled

298

Results

unpublished

Results date posted

2021 Year 01 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The median age was 63.5 years old. The mean body mass index (BMI) was 23.5 kg/m2. The median duration of follow-up was 9.0 years. During 10 years follow-up, 74 of 298 patients was classified into Progressive Renal Decline (PRD).

Participant flow

A total of 298 patients were enrolled for the data analysis. These participants represent approximately 68% of the whole cohort of the patients enrolled from April to June 2006 (n=429) after excluding the following; those who had incomplete laboratory data for analysis (n=4), patients with eGFR more than 120 mL/min/1.73m2 (n=16), those who suffered from hepatic diseases (n=4) and other kidney diseases (n=2) during the follow-up. In addition, patients with Gilbert syndrome were excluded in this study (n=14). We excluded the participants who were followed up for less than one year (n=91).

Adverse events

none

Outcome measures

Progressive Renal Decline (PRD).
Composite endpoint (ESKD or doubling of serum creatinine levels), or 30% reduction in eGFR

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2006 Year 04 Month 01 Day

Date of IRB

2015 Year 09 Month 16 Day

Anticipated trial start date

2006 Year 04 Month 01 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We analyzed the data of blood test which were collected at the out patient department.


Management information

Registered date

2014 Year 12 Month 11 Day

Last modified on

2021 Year 01 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018528


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2021/10/20 211020 PRDカットオフ値リポジトリ用.xlsx